Tangier disease as a test of the reverse cholesterol transport hypothesis

Journal of Clinical Investigation

Volumn 106, Issue 10, 2000, Pages 1205-1207

  Tall, A R ^a   Wang, N ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; TANGIER DISEASE;

EID: 0033677229     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11538     Document Type: Note

References (31)

1. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men
2. High-density lipoproteins in human health and disease
3. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: Stimulation by high density lipoprotein and other agents
4. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol
5. Atherosclerosis
6. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats
7. Selective uptake of HDL cholesteryl esters is active in transgenic mice expressing human apolipoprotein A-I
8. ApoA-I knockout mice: Characterization of HDL metabolism in homozygores and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes
9. Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium
10. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
11. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
12. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease
13. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)
14. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
15. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
16. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
17. Specific binding of apoA-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1
18. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
19. ABCA1 is the cAMP-inducible receptor that mediates cholesterol secretion from macrophages
20. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
21. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
22. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
23. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
24. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph
25. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
26. Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice
27. A targeted mutation in the murine gene encoding the high density lipoprorein (HDL) receptor scavenger receptor class B rype I reveals its key role in HDL metabolism
28. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC 1): Evidence for sterol-dependent regulation in macrophages
29. Sterol-dependent transactivation of the ABC1 promoter by the liver X Receptor/Retinoid X receptor
30. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
31. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells